Garodia Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) ....
Awaiting price reaction for this filing.
Garodia Chemicals Ltd has informed BSE that its Board of Directors will meet on Friday, February 13, 2026, to consider and approve the unaudited financial results along with the auditors' limited review report for the quarter ended December 31, 2025 (Q3 FY26). The trading window for designated persons and their immediate relatives remains closed since January 1, 2026, and will reopen 48 hours after the results are declared, in compliance with insider trading regulations. No financial figures or business details have been disclosed in this intimation; only the meeting agenda and regulatory compliance details are provided.
This is a routine regulatory filing ahead of the Q3 FY26 earnings announcement, with no direct impact on the stock price. Investors should watch the February 13, 2026 results for actual revenue, profit, and margin trends, as the trading window closure signals results are expected in the coming days.